{"abstract": "Investors shouldn\u2019t put Genzyme on the block. The company should divest its noncore businesses and fix its manufacturing problems. The payoffs will come later.", "web_url": "https://www.nytimes.com/2010/01/18/business/18views.html", "snippet": "Investors shouldn\u2019t put Genzyme on the block. The company should divest its noncore businesses and fix its manufacturing problems. The payoffs will come later.", "lead_paragraph": "Genzyme, a $14 billion biotechnology company, is getting a much-needed shake-up. Relational Investors, an investor in the company, is doing it by, at least for the moment, backing its management.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2010/01/18/business/18views_CA0/thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2010/01/18/business/18views_CA0/thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}], "headline": {"main": "At Genzyme, a Long View", "kicker": "Reuters BreakingViews", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "ImClone Systems Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Company Reports", "rank": 3, "major": "N"}, {"name": "subject", "value": "Boards of Directors", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Biogen Idec Incorporated", "rank": 5, "major": "N"}, {"name": "persons", "value": "Icahn, Carl C", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Bare Escentuals, Incorporated", "rank": 7, "major": "N"}, {"name": "subject", "value": "Sales", "rank": 8, "major": "N"}, {"name": "organizations", "value": "MedImmune Inc", "rank": 9, "major": "N"}, {"name": "organizations", "value": "Celgene Corporation", "rank": 10, "major": "N"}, {"name": "persons", "value": "Whitworth, Ralph V", "rank": 11, "major": "N"}, {"name": "organizations", "value": "Relational Investors LLC", "rank": 12, "major": "N"}, {"name": "organizations", "value": "Genzyme Corp", "rank": 13, "major": "N"}, {"name": "subject", "value": "Biotechnology", "rank": 14, "major": "N"}], "pub_date": "2010-01-18T03:11:10+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "", "person": [], "organization": null}, "type_of_material": "News", "_id": "nyt://article/9327992d-e4b2-514d-80c9-fb9b94d8dc10", "word_count": 743, "uri": "nyt://article/9327992d-e4b2-514d-80c9-fb9b94d8dc10"}